Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity
- PMID: 22938897
- PMCID: PMC3488959
- DOI: 10.1016/j.surg.2012.06.013
Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity
Abstract
Background: Controversy exists regarding the use of concurrent cholecystectomy during Roux-en-Y gastric bypass performed for morbid obesity.
Methods: A decision model was developed to evaluate the cost-effectiveness of current strategies: routine concurrent cholecystectomy, Roux-en-Y gastric bypass alone with or without postoperative ursodiol therapy, and selective cholecystectomy based on preoperative findings on ultrasonography. Probabilities were obtained from a comprehensive literature review. Costs and hospital days were obtained from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. One-way sensitivity analyses were performed.
Results: The least expensive strategy was to perform RYGB alone without preoperative ultrasonography, with an average cost (over RYGB costs) of $537 per patient. RYGB with concurrent cholecystectomy had a cost of $631. Selective cholecystectomy based on preoperative ultrasonography was dominated by the other 2 strategies. Our model was most sensitive to the probability of developing gallbladder-related symptoms after RYGB alone. When the incidence of gallbladder-related symptoms was <4.6%, the dominant strategy was to perform a RYGB alone without preoperative ultrasonography. For values >6.9%, performing concurrent cholecystectomy at the time of the RYGB was superior to other strategies. When ursodiol was used, the least expensive strategy was to perform a concurrent cholecystectomy during RYGB.
Conclusion: The main factor determining the most cost-effective strategy is the incidence of gallbladder-related symptoms after RYGB. The use of ursodiol was associated with an increase in cost that does not justify its use after RYGB. Finally, selective cholecystectomy based on preoperative ultrasonography was dominated by the other strategies in the scenarios evaluated.
Published by Mosby, Inc.
Figures
Similar articles
-
Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?Surg Obes Relat Dis. 2005 Nov-Dec;1(6):555-60. doi: 10.1016/j.soard.2005.08.002. Epub 2005 Sep 28. Surg Obes Relat Dis. 2005. PMID: 16925290
-
Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass.Surg Obes Relat Dis. 2006 Jan-Feb;2(1):41-6; discussion 46-7. doi: 10.1016/j.soard.2005.10.006. Epub 2006 Jan 4. Surg Obes Relat Dis. 2006. PMID: 16925315
-
Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass.Surg Endosc. 2015 Nov;29(11):3106-11. doi: 10.1007/s00464-014-4033-5. Epub 2014 Dec 17. Surg Endosc. 2015. PMID: 25515986
-
Systematic review of economic evaluation of laparotomy versus laparoscopy for patients submitted to Roux-en-Y gastric bypass.PLoS One. 2014 Jun 19;9(6):e99976. doi: 10.1371/journal.pone.0099976. eCollection 2014. PLoS One. 2014. PMID: 24945704 Free PMC article. Review.
-
The future of the Roux-en-Y gastric bypass.Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):777-84. doi: 10.1586/17474124.2016.1169921. Epub 2016 Apr 6. Expert Rev Gastroenterol Hepatol. 2016. PMID: 27027414 Review.
Cited by
-
The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery-An International Expert Survey.Obes Surg. 2024 Apr;34(4):1086-1096. doi: 10.1007/s11695-024-07101-y. Epub 2024 Feb 24. Obes Surg. 2024. PMID: 38400945
-
The outcome of concomitant cholecystectomy with bariatric surgery: a retrospective cohort study.Ann Med Surg (Lond). 2023 Mar 27;85(4):718-721. doi: 10.1097/MS9.0000000000000339. eCollection 2023 Apr. Ann Med Surg (Lond). 2023. PMID: 37113933 Free PMC article.
-
Incidence of symptomatic gallstones after bariatric surgery: the impact of expectant management.Langenbecks Arch Surg. 2023 Apr 24;408(1):160. doi: 10.1007/s00423-023-02904-6. Langenbecks Arch Surg. 2023. PMID: 37093281 Free PMC article.
-
Management of biliary stones in bariatric surgery.Ther Adv Gastrointest Endosc. 2022 Jun 19;15:26317745221105087. doi: 10.1177/26317745221105087. eCollection 2022 Jan-Dec. Ther Adv Gastrointest Endosc. 2022. PMID: 36388729 Free PMC article. Review.
-
Choledocholithiasis after Bariatric Surgery-More than a Stone's Throw to Reach?J Gastrointest Surg. 2018 Mar;22(3):529-537. doi: 10.1007/s11605-017-3634-4. Epub 2017 Nov 30. J Gastrointest Surg. 2018. PMID: 29192385 Review.
References
-
- Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47. - PubMed
-
- Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4:464–9. - PubMed
-
- Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;154:193–200. - PubMed
-
- Choban PS, Onyejekwe J, Burge JC, Flancbaum L. A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity. J Am Coll Surg. 1999;188:491–7. - PubMed
-
- Foley EF, Benotti PN, Borlase BC, Hollingshead J, Black-burn GL. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg. 1992;163:294–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
